Home » Stocks » Beyond Air

Beyond Air, Inc. (XAIR)

Stock Price: $5.44 USD -0.17 (-3.03%)
Updated Oct 27, 2020 4:00 PM EDT - Market closed
After-hours: $5.43 -0.01 (-0.18%) Oct 27, 5:02 PM

Stock Price Chart

Key Info

Market Cap 93.28M
Revenue (ttm) 991,796
Net Income (ttm) -20.50M
Shares Out 17.15M
EPS (ttm) -1.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 27, 2020
Last Price $5.44
Previous Close $5.61
Change ($) -0.17
Change (%) -3.03%
Day's Open 5.57
Day's Range 5.40 - 5.57
Day's Volume 49,152
52-Week Range 3.45 - 12.50

More Stats

Market Cap 93.28M
Enterprise Value 73.82M
Earnings Date (est) Nov 11, 2020
Ex-Dividend Date n/a
Shares Outstanding 17.15M
Float 14.19M
EPS (basic) -1.53
EPS (diluted) -1.53
FCF / Share -1.10
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.54M
Short Ratio 12.25
Short % of Float 10.85%
Beta -0.68
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 94.05
PB Ratio 5.58
Revenue 991,796
Operating Income -20.86M
Net Income -20.50M
Free Cash Flow -18.11M
Net Cash 19.46M
Net Cash / Share 1.13
Gross Margin 140.16%
Operating Margin -2,103.26%
Profit Margin -2,120.00%
FCF Margin -1,825.94%
ROA -65.20%
ROE -157.11%
ROIC -473.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$13.25*
(143.57% upside)
Low
9.00
Current: $5.44
High
17.00
Target: 13.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016
Revenue1.397.72--
Revenue Growth-82%---
Gross Profit1.397.72--
Operating Income-18.14-3.06-11.07-2.33
Net Income20.99-6.56-18.043.72
Shares Outstanding11.518.506.001.45
Earnings Per Share-1.78-0.77-3.01-2.69
Operating Cash Flow-15.251.34-7.12-0.69
Capital Expenditures-0.04-0.06-0.240.01
Free Cash Flow-15.291.28-7.36-0.68
Cash & Equivalents25.477.901.810.01
Total Debt4.880.260.033.31
Net Cash / Debt20.597.641.78-3.31
Assets27.439.432.190.24
Liabilities9.345.4010.574.93
Book Value18.094.02-8.38-4.70
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Beyond Air, Inc.
Country United States
Employees 23
CEO Steven A. Lisi

Stock Information

Ticker Symbol XAIR
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: XAIR

Description

Beyond Air, a clinical-stage medical device and biopharmaceutical company, develops inhaled nitric oxide (NO) to treat respiratory infections, and gaseous NO to treat solid tumors. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of lung infections, persistent pulmonary hypertension of the newborn, severe acute respiratory syndrome coronavirus 2, bronchiolitis, and nontuberculous mycobacteria.The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.